Learn More
Apexbio Technology LLC DiscoveryProbe™ Anti-cancer Compound Library Plus 100uL/well(10 mM solution),96 Well Deep Well Plate

Supplier: Apexbio Technology LLC L1023P0.096
DiscoveryProbe Anti-cancer Compound Library comprises 1 164 bioactive compounds targeting multiple oncological pathways with documented activity against cancers including leukemia lymphoma lung and breast cancer The library integrates compounds approved by globally recognized regulatory authorities such as FDA and EMA as well as preclinical candidates extensively documented in oncology research Compounds are selected based on clearly-defined mechanisms including kinase inhibition apoptosis induction cell-cycle regulation and epigenetic modulation Representative agents within the library include Paclitaxel Imatinib Sorafenib and Vorinostat This library is suitable for cancer biology research mechanism-of-action studies drug repurposing screening and preliminary evaluations in therapeutic development contexts
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.